merck

indiatoday.intoday.in

Eli Lilly's Mounjaro Becomes World's Top-Selling Drug in First Quarter

Mounjaro generated $8.7 billion in sales during the first quarter, surpassing Merck's Keytruda which recorded $7.9 billion. Keytruda had held the position of the world's best-selling drug since the beginning of 2023. The shift reflects changing revenue rankings among leading phar…

MO

2 sources